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Abstract: The use of herbomineral formulations for different chronic diseases is gaining popularity because these natural 
formulations have fewer side effects, a higher safety profile, and more cost effectiveness. A new proprietary herbomineral 
formulation composed of herbs and certain minerals was formulated, consisting of the herbal root extract ashwagandha and the 
minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the immunomodulatory potential of a Biofield 
Energy Healing (The Trivedi Effect
®
) Treatment on the herbomineral formulation in female Sprague Dawley rats. The test 
formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the 
other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely 
from eighteen renowned Biofield Energy Healers. Immunomodulatory potential, humoral immune response, paw volume, 
hematological study, biochemistry, body weight, feed intake and histopathology analysis were performed. Humoral immune 
response data showed increased (p≤0.01) primary antibody titre by 124.7% in the Biofield Treatment test formulation (G3), 
while the untreated test formulation group (G4) showed decreased antibody titre compared with the disease control group (G2). 
The secondary antibody titre value in the G3 group was also altered compared with the G2 group. Delayed type 
hypersensitivity (DTH) data suggest that the Biofield Energy Treated test formulation group (G3) showed a significant 
decrease in paw volume by 128.57% with respect to the G2 group. Hematology and biochemistry analysis showed altered 
values, as increased MCHC and RBC count by 138.09% and 7.24%, respectively in the G3 group compared with the G2 and 
G4 group. However, the platelet count was increased by 17.70% in the G3 group compared with the G2 group. The level of 
blood urea nitrogen was decreased by 10.90% in the G3 level compared with the G2 group. However, the levels of magnesium 
and phosphorus were increased by 13.29% and 6.28%, respectively in the G3 compared with the G2 group. Further, the change 
in body weight, feed consumption, organ to body weight ratio data, and histopathology examination did not suggest any 
statistical difference, which depicts that the Biofield Energy Treated test formulations was found to be safe. These data suggest 
that the Biofield Treated test formulation can be used for autoimmune and inflammatory diseases such as Rheumatoid arthritis, 
Alzheimer’s disease, Atherosclerosis, Dermatitis, Diverticulitis, Diabetes, etc. along with enhancing stress management and 
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anti-aging by improving overall health. 
Keywords: Biofield Energy Healing Treatment, Biofield Energy Healers, The Trivedi Effect®, Immunomodulation, 
Herbomineral Formulation, Paw Volume, Autoimmunity, Anti-Aging 
 
1. Introduction 
Natural products derived from plants and minerals are 
always regarded as the primary source for new herbomineral 
formulations for overall health [1]. In developed and 
developing countries alike, medicinal plant-derived drugs are 
continuously gaining popularity due to their natural origin 
and low side effects. Many traditional and complementary 
medicines are derived from medicinal plants, minerals, and 
organic matter, which are commonly used for the prevention 
and treatment of many diseases [2]. According to World 
Health Organization (WHO), medicinal plants are always the 
target of most of the pharmaceutical companies for new 
formulations [3], due to the presence of one or more active 
phytoconstituents [4]. Hence, the authors of this study used a 
new proprietary herbomineral formulation with a 
combination of the herbal root extract ashwagandha and three 
minerals viz. zinc, magnesium, and selenium as a basis to 
investigate ways to improve its immunomodulatory activity. 
Each constituent of the test formulation is reported for 
important pharmacological activities, such as ashwagandha 
(Withania somnifera) that belongs to the family Solanaceae, 
commonly used as alternative therapies [5, 6] due to the 
presence of active molecule like withanolides [7]. Apart from 
its common attributes such as antibacterial, 
immunomodulatory and antitumor effects, many clinical and 
preclinical data have been available with respect to the 
immunomodulatory impact [8, 9]. The importance of 
minerals such as selenium, zinc, and magnesium to modulate 
the immune system has been well-defined [10].  
Scientific research has been reported that due to the 
combination of minerals, herbal medicines have been found 
to exhibit a high level of phagocytic index and an improved 
antibody titre [11]. These formulations can be used for better 
therapeutic effect in immune compromised patients that are 
affected by cardiovascular diseases, age, stress related 
diseases, cancer, and autoimmune disorders. Along with the 
herbomineral formulations, the Biofield Energy Healers in 
this study have used Energy Medicine (Biofield Energy 
Healing Treatment) as a complementary and alternative 
approach to study the impact of the Biofield Energy 
Treatment on the herbomineral formulation for its 
immunomodulatory potential in female Sprague Dawley rats. 
In recent years, several scientific reports and clinical trials 
have revealed the useful effects of Biofield Energy 
Treatments, which has shown enhanced immune function in 
cases of cervical cancer patients with therapeutic touch [12], 
massage therapy [13], etc. Complementary and Alternative 
Medicine (CAM) therapies are now rising as preferred 
models of treatment, among which Biofield Therapy (or 
Healing Modalities) is one approach that has been reported to 
have several benefits to enhance physical, mental and 
emotional human wellness. The National Center of 
Complementary and Integrative Health (NCCIH) has 
recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health care 
approach in addition to other therapies, medicines and 
practices such as natural products, deep breathing, yoga, Tai 
Chi, Qi Gong, chiropractic/osteopathic manipulation, 
meditation, massage, special diets, homeopathy, progressive 
relaxation, guided imagery, acupressure, acupuncture, 
relaxation techniques, hypnotherapy, healing touch, 
movement therapy, pilates, Rolfing structural integration, 
mindfulness, Ayurvedic medicine, traditional Chinese herbs 
and medicines, naturopathy, essential oils, aromatherapy, 
Reiki and cranial sacral therapy. The Human Biofield is a 
subtle energy that has the capacity to work in an effective 
manner [14]. Complementary and Alternative Medicine 
(CAM) therapies have been practiced worldwide with 
reported clinical benefits in different health disease profiles 
[15]. This energy can be harnessed and transmitted by 
individuals into living and non-living things via the process 
of Biofield Energy Healing. Biofield Energy Treatment (The 
Trivedi Effect
®
) has been published in numerous peer-
reviewed science journals with significant outcomes in many 
scientific fields such as cancer research [16, 17], altered 
antimicrobial sensitivity of pathogenic microbes in 
microbiology [18-21], genetics [22, 23], altered physical and 
chemical properties of pharmaceutical compounds [24-27], 
improved overall growth and yield of plants in agricultural 
science [28-31], and changing the structure of the atom in 
relation to various metals, ceramics, polymers and chemicals 
in materials science [32-35]. 
The authors of this study want to evaluate the impact of 
the Biofield Energy Treatment (The Trivedi Effect
®
) on the 
given herbomineral formulation, which might improve the 
immunomodulatory function with respect to antibody titre, 
delayed type hypersensitivity reaction, body weight change, 
feed consumption, hematological parameters, and serum 
biochemistry using standard assays.  
2. Material and Methods 
2.1. Chemicals and Reagents 
Pyrogallol and sodium carboxymethyl cellulose (CMC) 
were purchased from Sigma Chemical Co. (St. Louis, MO). 
Withania somnifera (Ashwagandha) root extract powder 
(≥5% of total withanolides) was procured from Sanat 
Products Ltd., India. Zinc chloride and magnesium (II) 
gluconate hydrate were procured from TCI, Japan. Sodium 
selenate was procured from Alfa Aesar, USA. Levamisole 
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was procured from Sigma, USA. All other chemicals used in 
the experiment were of analytical grade available in India.  
2.2. Laboratory Animals  
A total number of 30 healthy female Sprague Dawley 
rats, weighing between 150-250 grams, were used for the 
study. The animals were purchased from M/s. Vivo Biotech 
Ltd., Hyderabad, India for this experiment. Standard normal 
rodent diet was procured from M/s. Golden feeds, Mehrauli, 
New Delhi, India and provided ad libitum to all the groups 
of animals during the experiment under controlled 
conditions with a temperature of 22 ± 3°C, humidity of 30% 
to 70% and a 12-hour light/12-hour dark cycle. The animals 
were acclimatized for 5 days prior to the experiment, and 
all were accessed once daily for clinical signs, behaviors, 
morbidity and mortality. All the procedures were in strict 
accordance with the Guide for the Care and Use of 
Laboratory Animals published by the US National Institutes 
of Health. The approval of the Institutional Animal Ethics 
Committee that was obtained prior to carrying out the 
animal experiment. 
2.3. Biofield Energy Treatment Strategies 
The test formulation was divided into two parts. One part 
of the test formulation was treated with Biofield Energy by 
renowned Biofield Energy Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation did 
not receive any sort of treatment and was defined as the 
untreated test formulation. This Biofield Energy Treatment 
was provided through a group of eighteen Biofield Energy 
Healers who participated in this study and performed the 
Biofield Energy Treatment remotely. Eleven Biofield Energy 
Healers were remotely located in the U.S.A, four were 
remotely located in Canada, two in Finland, and one of which 
was remotely located in Albania, while the test herbomineral 
formulation was located in the research laboratory of Dabur 
Research Foundation, New Delhi, India. This Biofield 
Energy Treatment was administered for 5 minutes through 
the Healer’s unique Energy Transmission process remotely to 
the test formulation under laboratory conditions. None of the 
Biofield Energy Healers in this study visited the laboratory in 
person, nor had any contact with the herbomineral samples. 
Further, the control group was treated with a “sham” healer 
for comparative purposes. The sham healer did not have any 
knowledge about the Biofield Energy Treatment. After that, 
the Biofield Energy treated and untreated samples were kept 
in similar sealed conditions and used for identification of 
immunological parameters.  
2.4. Antigen (Sheep RBC) 
The fresh sheep blood was collected aseptically from the 
jugular vein of a healthy sheep and transferred immediately 
to the heparinized tube. The collected erythrocytes were 
separated from plasma by centrifugation (400 g, 10°C, 10 
minutes), washed twice with the normal saline and then 
further diluted in saline, which were analyzed using 
Hematology analyzer (Abbott Model-CD-3700). Based on 
the number of erythrocytes, the samples were further diluted 
(using saline) before injecting to the rat [36]. 
2.5. Experimental Procedure 
After 5 days of acclimatization, the animals were grouped 
(G) based on the body weight. G1 (normal control) received 
oral suspension of 0.5% carboxy methyl cellulose-sodium 
salt via gavage. G2 (disease control) group animals received 
pyrogallol at a dose of 100 mg/kg through intraperitoneal 
(i.p.) route once daily for 7 days. G3 group animals received 
the Biofield Energy Treated test formulation (1105.005 
mg/kg b.wt, p.o.). G4 group animals received untreated test 
formulation at the same dose orally, while G5 group animals 
received levamisole at a dose of 50 mg/kg p.o. from day 1 to 
day 22. All the animals except normal control group (G1) 
received pyrogallol at a dose of 100 mg/kg through i.p. route 
once daily from day 1 to day 7. The animals were treated 
with the Biofield Energy Treated and untreated herbomineral 
formulation to the G3 and G4 group animals respectively, 1 
hour before pyrogallol challenge in the morning once daily 
for 22 days. On day 7
th
 and 13
th
, all the animals in G2 to G5 
except normal control (G1) were challenged with sheep red 
blood cells (sRBC) (0.5 X 10
9
/100 gm; i.p.), as the antigenic 
material to sensitize them for immunological parameters. On 
day 13
th
 and 20
th
, blood was collected from retro-orbital 
plexus and subjected to hemagglutination test to evaluate the 
humoral immune response. On same day 20
th
, the animals 
were challenged with sheep RBC (0.5 x 10
9
 cells/50 µL/rat) 
in sub-planter region and on 22
nd
 (48 hours) day, paw volume 
was measured to evaluate the cellular immune response. The 
treatment was continued to all the tested groups (G1 to G5) 
with 5 mL/kg body weight as dose volume. The body weight 
and food consumption were measured daily before treatment. 
On day 22, the animals were kept under fasting overnight, 
while on day 23
rd
 blood was collected again from the retro-
orbital plexus from each animal under anaesthetic condition 
using isoflurane. Whole blood was analysed for 
haematological parameters and the serum was analysed for 
biochemistry parameters. At the end of the study, animals 
were euthanized by CO2 asphyxiation as per in-house 
approved standard protocol. Different organs of all animals 
were excised, weighed and preserved for histopathological 
analysis. 
2.6. Determination of Humoral Immune Response 
Approximately 25 µL of serum was serially diluted with 
the 25 µL of phosphate-buffered saline. The sRBC (0.025 x 
10
9
 cells) was added to each of these dilutions and incubated 
at 37°C for 1 hour. The rank of minimum dilution that 
exhibited hemagglutination was considered as an antibody 
titre. The level of antibody titre on day 13
th
 of the experiment 
was considered as the primary humoral immune response, 
while antibody titre on day 20
th
 was considered as the 
secondary humoral immune response [37]. 
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2.7. Determination of Paw Volume (Delayed Type 
Hypersensitivity) 
The cellular immune response was assayed by the footpad 
reaction method. The edema was induced in the right paw of 
rats by injecting sRBC (0.025 x 10
9
 cells) in the sub-plantar 
region. The increase in the paw volume after 24 hours (on day 
21) was assessed on digital plethysmometer (Pan Lab, Spain). 
The mean percentage change in paw volume was considered as 
delayed type of hypersensitivity and as an index of cell-
mediated immunity. The volume of the left hind paw, injected 
similarly with phosphate-buffered saline, served as control. 
2.8. Determination of Hematological and Biochemical 
Parameters 
After fasting for 12 to 16 hours on day 23
rd
 of the 
experiment, blood was collected from the retro-orbital plexus 
using heparinized or non-heparinized capillary tubes. One 
portion of the blood was kept in plain bottles from which 
serum was collected and stored for biochemical analysis. The 
other portion was directly subjected for the estimation of 
various hematological parameters using standard instruments. 
The levels of hemoglobin (Hb), red blood cell count (RBC), 
packed cell volume (PCV), mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC) and platelets 
were analyzed in the blood samples in all experimental 
groups. Further, the levels of magnesium, blood urea, 
creatinine, uric acid, calcium, phosphorus, potassium, 
sodium, and chloride ion concentration were analyzed using 
a Hematology analyzer (Abbott Model-CD-3700) [38].  
2.9. Determination of Body Weight and Feed Intake 
Body weight and feed consumption of all the animals in 
various experimental groups were measured daily. Briefly, the 
weight of daily feed supply and the left-over by the following 
days were recorded and the difference was taken as the daily 
feed intake. The average of the feed intake was computed for 
every three days of the experimental period [39]. 
2.10. Clinical Sign and Symptoms 
Animal clinical sign and symptoms were evaluated once 
daily throughout the experiment in accordance with in-house 
protocol [40] with slight modification. Animals found in a 
moribund condition or enduring signs of severe distress were 
humanely euthanized. Abnormal findings were recorded with 
the time of onset and disappearance.  
2.11. Measurement of Relative Organ Weight and 
Histopathology 
At the end of the experiment, rats were dissected and the 
whole liver, kidneys, hearts, spleens, lungs and uterus were 
excised, freed of fat, blotted with clean tissue paper, and then 
weighed. The organ to body weight ratio was determined by 
comparing the weight of each organ with the final body 
weight of each rat. Defined samples were placed in 10% 
neutral buffered formalin for histopathological examination. 
2.12. Statistical Analysis 
Data were expressed as mean ± standard error of mean 
(SEM) and were subjected to Student’s t-test. Statistical 
significance was considered at p≤0.05. 
3. Results and Discussion 
3.1. Effect of the Test Formulation on Humoral Immune 
Response 
The results of primary and secondary humoral immune 
response of the test formulation after the Biofield Treatment 
are summarized in the Table 1. The values of primary and 
secondary antibody titre in the disease control groups were 
19.0 ± 4.67 and 28.0 ± 4.00, respectively. After treatment with 
the Biofield Energy Treated test formulation, the primary 
antibody titre was significantly increased (p<0.01), while 
secondary antibody titre was decreased compared with the 
disease control group. However, the untreated test formulation 
did not found any significant effect, so the Biofield Energy 
Treated test formulation showed a better result in comparison 
with the untreated test formulation. The values of primary 
antibody titre in the untreated test formulation was decreased 
compared with the Biofield Energy Treated test formulation. 
However, in case of secondary titre, the Biofield Energy 
Treated test formulation showed lower value (14.7 ± 1.33) 
compared with the untreated product test formulation (18.7 ± 
2.67) as well as disease control group.  
Table 1. The effect of the test formulation on humoral immune response in female rats. 
S. No Group  Primary HA titre Secondary HA titre 
1. Disease control 19.0 ± 4.67 28.0 ± 4.00 
2. Biofield Treated test formulation 42.7 ± 18.78** 14.7 ± 1.33 
3. Untreated test formulation 1.0 ± 0.00 18.7 ± 2.67 
4. Levamisole 17.8 ± 6.49 29.3 ± 2.67 
Values are expressed as the mean ± SEM. **p<0.01 compared with the disease control.  
The Biofield Energy Treated test formulation group 
showed a significantly improved primary antibody titre level 
by 124.7% compared with the disease control, while the 
untreated test formulation showed a decreased titre value by 
94.74% compared with the disease control. These results 
suggest that the Biofield Energy Healing Treatment further 
improved the immunomodulatory effect of test herbomineral 
formulation, compared with the untreated test formulation. 
Overall, the results of the antibody titre suggest that the 
Biofield Energy Treated test formulation exhibited a potent 
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immunomodulatory effect for humoral immunity with 
improved primary antibody synthesis under inflammatory 
stimulus. The increased primary antibody titre values in the 
Biofield Energy Treated test formulation clearly states that 
Biofield Energy has the capacity to modulate the humoral 
immunity profile of the test formulation. This could be 
assumed that after administration of the Biofield Energy 
Treated test formulation, specific antibodies were produced 
against antigen, in order to fight against infection, which 
could improve the overall immunity [41]. However, the 
humoral immune response activation by the Biofield Energy 
Treated test formulation could indicate improved 
responsiveness of the macrophages/B-lymphocytes subsets in 
these hosts [42]. 
3.2. Estimation of Delayed Type Hypersensitivity (Paw 
Volume) 
The effects of the Biofield Energy Treated test formulation 
with respect to delayed type hypersensitivity reaction in 
female rats were measured and are presented in the Figure 1. 
The results suggest that the mean paw edema volume in G1, 
G2, G3, G4, and G5 groups were 00.04 ± 0.01, 00.07 ± 0.02, 
-00.02 ± 0.02, 00.05 ± 0.04, and 00.84 ± 0.04 mL, 
respectively. However, the Biofield Energy Treated test 
formulation (G3) showed a significant decrease in paw 
volume by 128.57% with respect to the disease control 
group. Overall, data suggest that the Biofield Energy Treated 
test formulation exhibited significant immunomodulatory 
effect on the basis of altered paw volume. It can be assumed 
that the constituents present in the test formulation are 
responsible for a delayed type hypersensitivity reaction, 
however Biofield Energy Healing (The Trivedi Effect
®
) 
Treatment significantly altered the immune response 
compared with the untreated test formulation.  
 
Figure 1. Effect of the test formulation on rat paw volume (delayed-type 
hypersensitivity). G1: Normal Control; G2: Disease Control: G3: Biofield 
Energy Treated test formulation; G4: Untreated test formulation; G5: 
Levamisole. All values are expressed as the mean ± SEM (n = 6).  
3.3. Effect of the Biofield Energy Treated Herbomineral 
Formulation on Hematological Parameters 
The results of the Biofield Energy Treated and untreated 
test formulation administration in experimental animals show 
an altered hematological profile but did not show any 
statistically significant difference among different group with 
respect to the disease control group. The results are 
summarized in Table 2, which did not show any unfavorable 
or abnormal hematological tested parameters. The tested 
hematological parameters such as RBC, Hb, PCV, MCV, 
MCH, and MCHC showed slight alteration with respect to 
the normal and disease control groups. The level of RBC 
showed a slight increase in all the tested groups compared 
with the normal control group (7.72 ± 0.23), but it was not 
significant. However, the Biofield Energy Treated test 
formulation showed an increase in RBC count (9.47 ± 0.08 
10
6
/	L) compared with the untreated test formulation (9.17 ± 
0.21 10
6
/	L). The RBC count was improved by 7.24% and 
3.85% in the Biofield Energy Treated and untreated test 
formulation, respectively with respect to the disease control 
group. However, it was reported in the animal study that 
ashwagandha root extract prevents myelosuppression in mice 
with improved hematological parameters such as RBC, Hb, 
WBC, and platelet count [43]. The study results are well 
corroborated with respect to the ashwagandha extract and 
other test formulation ingredients, further the Biofield Energy 
Treatment showed an improved efficacy of the test 
formulation with respect to the hematological parameters.  
Various other hematological parameters such as Hb, PCV, 
MCV, MCH, and MCHC showed slight alterations with 
respect to the normal and disease control groups. MCHC is 
defined as the derived value from the Hb measurement and the 
hematocrit. As, Hb denotes the amount of hemoglobin in a 
volume of blood, while hematocrit is defined as the ratio of the 
volume of red cells to the volume of whole blood. MCHC is 
considered as standard part of the complete blood count. The 
present experimental results showed a significant increase in 
the values of MCHC by 138.09%, while the untreated test 
formulation was not able to improve the MCHC percentage 
compared with the disease control group. Similarly, the platelet 
count in the normal control group was reported as 1047.50 ± 
113.10 thousand/mm
3
, which was decreased to 760.67 ± 67.37 
thousand/mm
3 
in the disease control group. However, the 
Biofield Energy Treated test formulation showed the platelet 
level was increased by 17.70% (895.33 ± 171.90 
thousand/mm
3
) compared with disease control values. Thus, it 
can be concluded that the test formulation showed overall 
improved hematological parameters such as RBC, MCHC, and 
platelet count. Scientific literature suggests that ashwagandha 
root extract has shown improved platelet counts in animals 
[44]. The experimental results were well supported with the 
literature data, as the new herbomineral proprietary 
formulation contains ashwagandha root extract along with 
important minerals. Ashwagandha root extract was reported 
without any toxic effect on the human erythrocytes [45], 
similar observations were reported in this experiment as no 
hemolysis was reported due to the test formulation at the tested 
concentration with respect to the normal control and disease 
control group. The minerals present in the test formulation 
were reported with improved hematological parameters and 
regarded as safe with good therapeutic effect [46].  
It can be suggested that the Biofield Energy Treated test 
formulation can be used to improve the RBC, MCHC, and 
platelet count that proved as better efficacy compared with 
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the untreated formulation.  
Table 2. Assessment of Hematology parameters after treatment with the test formulation in female rats. 
Group (G) RBC (106/	L) Hb (gm/dL) PCV (%) MCV (fl) 
1 7.72 ± 0.23 14.90 ± 0.55 43.52 ± 1.42 56.40 ± 1.11 
2 8.83 ± 0.22 17.00 ± 0.25 57.73 ± 0.86 62.03 ± 0.85 
3 9.47 ± 0.08 16.88 ± 0.18 59.73 ± 0.55 63.12 ± 0.48 
4 9.17 ± 0.21 16.22 ± 0.39 56.40 ± 1.09 61.17 ± 0.80 
5 9.65 ± 0.11 16.83 ± 0.23 58.88 ± 0.62 61.18 ± 0.71 
Table 2. Continued. 
Group (G) MCH (pg) MCHC (%) Platelet Count (thousand/mm3) RDW-CV 
1 19.28 ± 0.38 34.23 ± 0.25 1047.50 ± 113.10 0.13 ± 0.00 
2 18.18 ± 0.24 29.35 ± 0.21 760.67 ± 67.37 0.15 ± 0.00 
3 17.87 ± 0.20 69.88 ± 14.62* 895.33 ± 171.90 0.15 ± 0.00 
4 17.52 ± 0.19 28.70 ± 0.18 1060.83 ± 113.17 0.15 ± 0.00 
5 17.38 ± 0.22 28.48 ± 0.09 949.83 ± 135.07 0.15 ± 0.00 
All values are presented as mean ± SEM (n=6). G represents as group; G1: Normal control; G2: Disease control (Pyrogallol); G3: Biofield Energy Treated test 
formulation; G4: Untreated test formulation; G5: Reference compound (Levamisole). *p<0.05 compared to the disease control. Hb: Hemoglobin; RBC: Red 
blood count; PCV: Packed cell volume; MCV: Mean corpuscular volume; MCH: Mean corpuscular hemoglobin; MCHC: Mean corpuscular hemoglobin 
concentration; Red cell distribution width and volume (RDW-CV).  
3.4. Effect of the Biofield Energy Treated Test Formulation 
on Serum Biochemistry  
The effect of the Biofield Energy Treated test formulation 
with respect to the biochemical parameters was summarized 
in the Table 3. The biochemical parameters were studied and 
compared with respect to magnesium level, blood urea, 
creatinine, uric acid, calcium, phosphorus, sodium, potassium, 
and chloride ion concentrations. The results suggest that the 
values of blood urea was increased by 42.5% (56.10 ± 6.36 
mg/dL) in the disease control group, while in the Biofield 
Energy Treated test formulation group further decreased 
value by 10.90% was observed compared with the disease 
control group. The level of potassium ions in the Biofield 
Energy Treated test formulation group showed an increased 
level as 11.23 ± 4.25 mEq/L compared with the disease 
control (10.02 ± 1.51 mEq/L) and normal control group (5.32 
± 0.11 mEq/L). Similarly, the magnesium level was 
increased by 13.29% in the Biofield Energy Treated test 
formulation group (4.09 ± 0.28 mg/dL) compared with the 
disease control group (3.61 ± 0.16 mg/dL). The level of 
phosphorus was increased by 6.28% (12.68 ± 1.62 mg/dL) in 
the Biofield Energy Treated test formulation group compared 
with the disease control group (11.93 ± 0.90 mg/dL). 
However, the other tested biochemical parameters were also 
reported with altered values compared with the normal and 
disease control groups. However, overall results suggest that 
the Biofield Energy Treated test formulation group showed 
altered biochemical parameters after oral administration of 
test formulation in female rats compared with the disease 
control group. This suggest that the test formulation was non-
toxic with respect to the hematological parameters, as 
literature suggests that the constituents of test formulation 
like ashwagandha root extract did not find any serious 
toxicity or side effects and thus can be safely used for any 
acute and chronic treatment [47]. Each minerals used in the 
test formulation was already reported to be safe and 
beneficial, so it can be concluded that the Biofield Energy 
Treated test formulation showed better improved 
hematological and biochemical profiles compared with the 
untreated test formulation and found to be safe in all aspect.  
Table 3. Estimation of biochemical parameters after treatment with the test formulation in female rats. 
Group (G) Magnesium (mg/dL) Blood Urea (mg/dL) Creatinine (mg/dL) Uric Acid (mg/dL) 
1 2.61 ± 0.08 39.37 ± 2.25 0.60 ± 0.00 2.85 ± 0.37 
2 3.61 ± 0.16 56.10 ± 6.36 0.38 ± 0.06 9.05 ± 1.91 
3 4.09 ± 0.28 49.98 ± 3.69 0.40 ± 0.09 10.77 ± 3.59 
4 4.27 ± 0.28 57.03 ± 5.07 0.48 ± 0.09 13.18 ± 1.26 
5 3.35 ± 0.17 45.97 ± 4.95 0.45 ± 0.07 7.15 ± 2.33 
Table 3. Continued. 
Group (G) Calcium (mg/dL) Phosphorus (mg/dL) K+ (mEq/L) Na+ (mEq/L) Cl- (mEq/L) 
1 10.02 ± 0.14 8.00 ± 0.20 5.15 ± 0.09 142.37 ± 7.48 102.17 ± 0.17 
2 11.48 ± 1.12 11.93 ± 0.90 10.02 ± 1.51 143.85 ± 2.84 107.33 ± 2.91 
3 9.95 ± 0.41 12.68 ± 1.62 11.23 ± 4.25 138.00 ± 6.48 112.17 ± 1.40 
4 9.82 ± 0.49 14.20 ± 0.70 15.83 ± 2.54 131.00 ± 1.06 104.00 ± 1.41 
5 10.32 ± 0.26 10.77 ± 1.10 9.82 ± 2.27 144.00 ± 5.18 110.50 ± 3.21 
All values are presented as mean ± SEM (n=6). G represents as group; G1: Normal control; G2: Disease control (Pyrogallol); G3: Biofield Energy Treated test 
formulation; G4: Untreated test formulation; and G5: Reference compound (Levamisole). 
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3.5. Effect of the Test Formulation on Body Weight and 
Organ to Body Weight Ratio 
The effect of the Biofield Energy Treated test formulation 
administration on animal weight parameters of female rats 
were analyzed and presented in Table 4. The results reflect 
the change in body weight, as final weights were increased 
among all the tested groups. The mean body weight 
percentage difference in the Biofield Energy Treated test 
formulation group and untreated test formulation group did 
not have any significant difference compared with the disease 
control group. 
The results suggest that there was no significant change 
throughout the experimental period in relative organ weight 
parameters such as in liver, kidney, lungs, spleen, heart, 
ovaries, uterus, and brain with respect to the normal and 
disease control groups (Table 4). The results of relative organ 
weight suggest that in the disease control group, a slight 
increase was recorded, while after treatment with the Biofield 
Energy Treated test formulation, the organ weight reached 
normal level similar to the control group.  
Table 4. Effect of the test formulation on organ weight parameters of female rats. 
Relative weight (%) G1 G2 G3 G4 G5 
Liver 3.11 ± 0.13 3.28 ± 0.12 3.50 ± 0.14 3.54 ± 0.12 3.93 ± 0.14 
Kidney 0.75 ± 0.03 0.83 ± 0.03 0.76 ± 0.03 0.79 ± 0.03 0.94 ± 0.03 
Lungs 0.64 ± 0.02 0.75 ± 0.06 0.67 ± 0.04 0.65 ± 0.05 0.75 ± 0.03 
Spleen 0.31 ± 0.01 0.34 ± 0.02 0.35 ± 0.02 0.34 ± 0.02 0.33 ± 0.01 
Heart 0.40 ± 0.02 0.43 ± 0.03 0.45 ± 0.05 0.41 ± 0.03 0.45 ± 0.01 
Brain 0.84 ± 0.05 0.86 ± 0.05 0.84 ± 0.05 0.82 ± 0.03 0.93 ± 0.04 
Eyes 0.11 ± 0.01 0.13 ± 0.01 0.12 ± 0.01 0.11 ± 0.01 0.13 ± 0.01 
Ovary 0.08 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.10 ± 0.01 0.12 ± 0.01 
Uterus 0.28 ± 0.03 0.42 ± 0.05 0.36 ± 0.03 0.38 ± 0.07 0.46 ± 0.06 
Whole intestine  6.25 ± 0.20 5.88 ± 0.21 7.70 ± 0.21 7.50 ± 0.48 6.22 ± 0.25 
Values are presented as mean ± SEM (n=6). G represents as group; G1: Normal control; G2: Disease control (Pyrogallol); G3: Biofield Energy Treated test 
formulation; G4: Untreated test formulation; and G5: Reference compound (Levamisole). 
The increase in organ weight after any treatment or 
exposure to any substance could be correlated to the 
toxicological implications. If organ weights increase, it can 
be correlated with hypertrophy, while atrophy in the case of 
decreased organ weight conditions, while organ to body 
weight ratio is considered as a useful index for the 
identification of toxicological implications such as swelling, 
atrophy or hypertrophy [46]. However, the Biofield Energy 
Treated test formulation did not show any unfavorable 
interaction or inflammation/cellular constriction with tested 
organs which suggests the safe nature of the test 
herbomineral formulation. In this study, no significant 
change in an organ or body weight or unfavorable 
interactions has been found during the experimental period, 
which supports the nontoxic nature of the Biofield Energy 
Treated test formulation. 
3.6. Effect of the Biofield Energy Treated Test Formulation 
on Feed Intake 
The results of the animal feed intake measurement are 
shown in the Figure 2. The result suggests no treatment 
related change was observed throughout the experiment 
compared with the normal control group. The animals in the 
disease control group showed a slight decrease in mean feed 
intake in the Biofield Energy Treated test formulation group 
(15.44 ± 6.77 gm) compared with the normal (17.20 ± 8.29 
gm) and disease control group (16.78 ± 6.84 gm). Further, 
the levamisole group also showed a slight decrease in mean 
feed intake (15.79 ± 13.11 gm) compared with the normal 
and disease control groups. Overall, the results reflect no 
significant change in feed intake in animals after treatment 
with the Biofield Energy Treated and untreated test 
formulation, which depicts that the product is quite safe at 
the selected doses. The results suggest that the Biofield 
Energy Treated or untreated test formulation, did not have 
any concern with the appetite of the animals and could not 
relate to any consequential effects on their performances, as 
also reflected with no change in body weight parameters.  
 
Figure 2. The effect of the test formulation on feed intake of female rats. All 
values are presented as mean ± SEM (n=6). G represents as group; G1: 
Normal control; G2: Disease control (Pyrogallol); G3: Biofield Energy 
Treated test formulation; G4: Untreated test formulation; G5: Reference 
compound (Levamisole). 
3.7. Histopathological Study 
Histopathological analysis of kidney, brain, liver, heart, 
lungs, uterus and cervix were performed and the results 
suggest no toxicological changes with respect to treatment of 
all the experimental animals as compared with the normal 
and disease control group. Liver histopathology data suggest 
only minimal severity was observed in disease control, while 
test formulation treated groups showed centrizonal necrosis, 
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while the rest of the histopathology was reported as normal 
without having any severe lesions. On the basis of severity 
and incidence, histopathological findings suggest that the 
toxicological consideration might be irrelevant and incidental 
in nature, and was not related to the treatment. The detailed 
classification and severity score was summarized in Table 5, 
and microscopic organ sections are shown in Figure 3. 
Table 5. Histopathological finding after treatment with the test formulation in female rats. 
S. No. Organs and Findings Severity 
Experimental Groups 
G1 G2 G3 G4 G5 
1. Kidney - 0/6 0/6 0/6 0/6 0/6 
2. Brain - 0/6 0/6 0/6 0/6 0/6 
3. Liver -      
 
-Hepatocytic vacuolation  0/6 0/6 0/6 0/6 0/6 
-Centrizonal 1 0/6 1/6 4/6 4/6 0/6 
-Scattered  2/6 0/6 0/6 0/6 0/6 
4. Heart - 0/6 0/6 0/6 0/6 0/6 
5. Lungs - 0/6 0/6 0/6 0/6 0/6 
6. Uterus - 0/6 0/6 0/6 0/6 0/6 
7. Cervix - 0/6 0/6 0/6 0/6 0/6 
‘-’denotes the absence of indicative grading; 1 represents minimal severity; 0/6 denotes zero severity out of six animals. G represents as group; G1: Normal 
control; G2: Disease control (Pyrogallol); G3: Biofield Energy Treated test formulation; G4: Untreated test formulation; G5: Reference compound 
(Levamisole). 
 
Figure 3. Histopathological cross sections of major organs in female rats 
after treatment with the test formulation. G represents as group; G1: Normal 
control; G2: Disease control (Pyrogallol); G3: Biofield Energy Treated test 
formulation; G4: Untreated test formulation; G5: Reference compound 
(Levamisole). 
Biofield Energy Treatment is a kind of electromagnetic 
field or radiation therapy by Biofield Energy Healers, as 
reported that can improve the overall quality of life such as in 
case of cancer [48]. Biofield Energy migrates through the 
enviornmantal medium and rapidly propagates throughout 
the organism after treatment with The Trivedi Effect
®
-
Biofield Energy Healing. Hence, it might be suggested that 
Biofield Energy Treatment might improve the internal 
interferance of molecules used in the natural proprietary 
herbomineral formulation, which showed an imporved anti-
inflammatory and immunomodulatory activities compared 
with the untreated test formulation. Complementary and 
Alternate Medicine (CAM) has reported several advantages 
over the current preferred treatment approach [49, 50]. The 
important minerals required to boost-up the immune system 
along with the overall effective herbal extract of 
ashwagandha root can be defined as the powerful source of 
new herbomineral product, which could prooved better 
results compared with the existing herbal products or 
conventaional medicines.  
4. Conclusions 
Overall, it can be concluded that the newly formulated 
herbomineral test formulation after Biofield Energy 
Treatment by renowned Biofield Energy Healers showed an 
improved immunomodulatory effect, as suggested with 
increased antibody titre values. The Biofield Energy Treated 
test formulation group (G3) animals showed a significant 
increased primary antibody titre by 124.7% compared with 
the disease control group, indicating that the results were 
much better than the untreated test formulation. The results 
given of a delayed type hypersensitivity response suggest that 
paw volume was significantly decreased by 128.57% in the 
G3 group animals compared with the disease control group. 
Further, the G3 group animals showed improved hematology 
parameters RBC (7.24%), MCHC (138.09%) and platelets 
(17.70%) compared with the disease control. However, the 
serum biochemistry analysis in the Biofield Energy Treated 
herbomineral formulation group (G3) animals showed a 
decreased level of blood urea by 10.90%, while the 
magnesium and phosphorus level were increased by 13.29% 
and 6.28%, respectively compared with the disease control 
group. The Biofield Energy Treated and untreated test 
formulations did not find any toxic effects as reported 
without any sign of mortality, weight parameters, and feed 
intake during the course of the experiment. The test 
formulation was found to be safe and did not affect the 
animal appetite or performance throughout the experimental 
period. No treatment related gross lesion or microscopic 
findings were observed in any of the isolated rat organs from 
the treatment groups, and no significant change in the organ 
to body weight ratio was found compared with the disease 
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control group. Histopathological findings did not suggest any 
sign of severity after treatment at all the tested doses.  
Therefore, the Trivedi Effect
®
-Biofield Energy Healing 
administered remotely by the eighteen Biofield Energy Healers 
enhanced the herbomineral test formulation’s anti-
inflammatory and immunomodulatory properties without any 
side effects, and can be used as a herbomineral product to 
improve the overall health. Thus, the Biofield Energy Treated 
test formulation may act as an effective anti-inflammatory and 
immunomodulatory product, and it can be used as a 
Complementary and Alternative Medicine (CAM) with a safe 
therapeutic index for various autoimmune disorders such as 
Lupus, Systemic Lupus Erythematosus, Fibromyalgia, 
Addison Disease, Hashimoto Thyroiditis, Celiac Disease 
(gluten-sensitive enteropathy), Multiple Sclerosis, 
Dermatomyositis, Graves’ Disease, Myasthenia Gravis, 
Pernicious Anemia, Aplastic Anemia, Scleroderma, Psoriasis, 
Rheumatoid Arthritis, Reactive Arthritis, Type 1 Diabetes, 
Sjogren Syndrome, Crohn’s Disease, Vasculitis, Vitiligo, 
Chronic Fatigue Syndrome and Alopecia Areata, as well as 
inflammatory disorders such as Irritable Bowel Syndrome 
(IBS), Asthma, Ulcerative Colitis, Alzheimer’s Disease, 
Parkinson’s Disease, Atherosclerosis, Dermatitis, Hepatitis, 
and Diverticulitis. Further, the Biofield Energy Healing 
Treated test formulation can also be used in the prevention of 
immune-mediated tissue damage in cases of organ transplants 
(for example heart transplants, kidney transplants and liver 
transplants), for anti-aging, stress prevention and management, 
and in the improvement of overall health and quality of life.  
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